15th Annual Meeting of the Oligonucleotide Therapeutics Society, Munich, Germany

13 October 2019 - 16 October 2019


OTS Oligonucleotide Therapeutics Society

InteRNA Technologies will present 2 posters at the Oligonucleotide Therapeutics Society (OTS) annual meeting:

Sunday, October 13th during Poster Session I from 18.00-19.30

Poster #27  by Thijs de Gunst, MSc, Manager Preclinical Operations:

A.188 A novel lipid-based nanoparticle formulation mediating safe and robust functional delivery of siRNA/miRNA.
DE GUNST, T., YAHYANEJAD, S., DEN BOER, H., VOS, R., ALEMDEHY, F., TELFORD, B., VAN DEN BOSCH, M., STEGINK, M., VAN PINXTEREN, L., SCHAAPVELD, R. & JANICOT, M.


Monday, October 14th during Poster Session II from 17.35-19.30

Poster #138  by Marion van den Bosch, PhD, Scientist:

A.187 Transcriptome-wide analysis reveals novel insights into tumor suppressor function of 1B3 (a chemically-modified miR-193a-3p mimic).
VAN DEN BOSCH, M., YAHYANEJAD, S., ALEMDEHY, F., TELFORD, B., DE GUNST, T., DEN BOER, H., VOS, R., STEGINK, M., VAN PINXTEREN, L., SCHAAPVELD, R. & JANICOT, M.